A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)

Virginia Center for Reproductive Medicine

Status: Completed

Conditions: Infertility

Study type: Observational

Funder types: Other

Identifiers

NCT01139593

VCRM 5

Details and patient eligibility

About

This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI when taking their gonadotropin dosage in the morning (am) or evening (pm).

Enrollment: 128 patients

Sex: Female

Ages: 21 to 42 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• women between 21-42 undergoing IVF

Exclusion criteria

• women > 45,
• women with one ovary,
• donor egg,
• surrogacy,
• FET cycles,
• uterine problems,
• large fibroids

Trial design

128 participants in 2 patient groups

morning dose

Description:

women undergoing IVF/ICSi taking their gonadotropin dose in the am

evening dose

Description:

Women undergoing IVF/ICSI taking their gonadotropin in the evening